Cinclus Pharma says last Phase III HEEALING1 patient completes treatment
Cinclus Pharma Holding AB (publ) said the last patient in its Phase III HEEALING1 study completed the treatment period. Topline results are expected in Q4 2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.